AGP Executive Report
Last update: an hour agoDrug Control: Macau’s government has drafted amendments to its anti-drug law to add new substances to the drug list, including seven etomidate analogues linked to “space oil,” with an urgent legislative process planned. Medicine Safety: The Pharmaceutical Administration Bureau warned that Hong Kong’s Department of Health flagged a topical product (“Dermasa”) adulterated with Western prescription-only anaesthetics (lidocaine, tetracaine, prilocaine), urging residents not to buy or use it. Infant Formula Lead Scare: Health and related bureaus ordered removal and recall of Frisolac Prestige Stage 1 after lead exceeded Macau’s legal limit, set up a paediatric emergency “green channel,” and reported expanded follow-up testing with no lead-poisoning emergencies among those seeking care. Hospital Access & Privacy: From Aug 15, Family Medicine Clinics’ phone appointment system will only accept calls with caller ID to better protect patient data and reduce impersonation risks. Emergency Care Capacity: SSM said average public emergency department waiting times fell 10% year-on-year in H1, with Category 2 averaging 16 minutes, and highlighted added capacity from the Macau Medical Centre of Peking Union Medical College Hospital. UM Innovation Push: UM launched five science/tech faculties and two research institutes to strengthen innovation and talent for Macau’s diversification. Public Health & Wellness Work: A local study spotlighted spa therapists’ wellbeing in Macao, shaped by workplace relationships, financial stability, emotional resilience, and personal life factors.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
